financetom
Business
financetom
/
Business
/
Upstart Holdings Swings to Q2 Adjusted Loss, Revenue Declines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Upstart Holdings Swings to Q2 Adjusted Loss, Revenue Declines
Aug 7, 2024 1:50 AM

04:41 AM EDT, 08/07/2024 (MT Newswires) -- Upstart Holdings ( UPST ) reported Q2 adjusted loss Tuesday of $0.17 per diluted share, swinging from adjusted earnings of $0.06 a year earlier.

Analysts surveyed by Capital IQ expected a normalized loss of $0.39.

Revenue for the quarter ended June 30 was $127.6 million, compared with $135.8 million a year earlier.

Analysts polled by Capital IQ expected $124.5 million.

For Q3, the company expects revenue of about $150 million. That compares with the consensus estimate of $142.4 million from analysts polled by Capital IQ.

Shares of Upstart Holdings ( UPST ) rose more than 17% in pre-bell activity on Wednesday.

Price: 28.05, Change: +4.18, Percent Change: +17.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
Nov 7, 2025
Revised transaction values Metsera at up to $86.25 per share Metsera's ( MTSR ) Board of Directors unanimously recommends that Metsera ( MTSR ) stockholders approve the adoption of the amended Pfizer merger agreement and approve the merger with Pfizer Transaction creates real, certain and immediate value for Metsera's ( MTSR ) stockholders and ensures Metsera's ( MTSR ) important drug...
Metsera enters merger agreement with Pfizer
Metsera enters merger agreement with Pfizer
Nov 7, 2025
Nov 7 (Reuters) - Metsera ( MTSR ), an obesity drug developer, said on Friday that it has entered into an amended merger agreement with Pfizer ( PFE ), in which the New York-based company will acquire Metsera ( MTSR ) for up to $86.25 per share. Metsera's ( MTSR ) board has recommended that its shareholders approve the adoption...
Nvidia CEO Huang sees strong demand for Blackwell chips
Nvidia CEO Huang sees strong demand for Blackwell chips
Nov 7, 2025
HSINCHU, Taiwan, Nov 8 (Reuters) - Nvidia ( NVDA ) CEO Jensen Huang said on Saturday the company is experiencing very strong demand for its Blackwell chips. Huang told reporters that business was growing strongly and there would be shortages of different things. ...
US Justice Department probes meatpackers, attorney general says
US Justice Department probes meatpackers, attorney general says
Nov 7, 2025
WASHINGTON/CHICAGO (Reuters) -President Donald Trump on Friday accused meatpacking companies of driving up U.S. beef prices, which have hit records, through manipulation and collusion, and ordered the Justice Department to investigate. Attorney General Pam Bondi said in an X post the probe was under way and being run by Agriculture Secretary Brooke Rollins and Assistant Attorney General Gail Slater. Slater...
Copyright 2023-2026 - www.financetom.com All Rights Reserved